Grove Bank & Trust’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.18M | Buy |
3,253
+503
| +18% | +$172K | 0.12% | 108 |
|
|
2026
Q1 | $968K | Buy |
2,750
+4
| +0.1% | +$1.43K | 0.11% | 115 |
|
|
2025
Q4 | $899K | Buy |
2,746
+17
| +0.6% | +$5.39K | 0.1% | 127 |
|
|
2025
Q3 | $770K | Hold |
2,729
| – | – | 0.09% | 135 |
|
|
2025
Q2 | $762K | Sell |
2,729
-44
| -2% | -$12.5K | 0.1% | 132 |
|
|
2025
Q1 | $864K | Buy |
2,773
+23
| +0.8% | +$6.79K | 0.12% | 114 |
|
|
2024
Q4 | $717K | Buy |
2,750
+93
| +4% | +$27.6K | 0.1% | 124 |
|
|
2024
Q3 | $856K | Buy |
2,657
+105
| +4% | +$34.3K | 0.13% | 105 |
|
|
2024
Q2 | $797K | Sell |
2,552
-125
| -5% | -$36.7K | 0.13% | 103 |
|
|
2024
Q1 | $761K | Sell |
2,677
-2,072
| -44% | -$606K | 0.13% | 104 |
|
|
2023
Q4 | $1.37M | Sell |
4,749
-1,434
| -23% | -$391K | 0.25% | 74 |
|
|
2023
Q3 | $1.66M | Buy |
6,183
+603
| +11% | +$150K | 0.34% | 59 |
|
|
2023
Q2 | $1.24M | Buy |
5,580
+1,016
| +22% | +$236K | 0.25% | 75 |
|
|
2023
Q1 | $1.1M | Buy |
4,564
+574
| +14% | +$141K | 0.23% | 84 |
|
|
2022
Q4 | $1.05M | Sell |
3,990
-792
| -17% | -$212K | 0.23% | 87 |
|
|
2022
Q3 | $1.08M | Buy |
4,782
+608
| +15% | +$147K | 0.27% | 78 |
|
|
2022
Q2 | $1.02M | Buy |
4,174
+117
| +3% | +$28.7K | 0.24% | 86 |
|
|
2022
Q1 | $981K | Buy |
4,057
+656
| +19% | +$151K | 0.19% | 105 |
|
|
2021
Q4 | $765K | Buy |
3,401
+215
| +7% | +$45.4K | 0.15% | 123 |
|
|
2021
Q3 | $678K | Sell |
3,186
-49
| -2% | -$11.3K | 0.14% | 122 |
|
|
2021
Q2 | $789K | Buy |
3,235
+63
| +2% | +$15.5K | 0.17% | 114 |
|
|
2021
Q1 | $789K | Buy |
3,172
+8
| +0.3% | +$1.91K | 0.19% | 107 |
|
|
2020
Q4 | $727K | Buy |
3,164
+133
| +4% | +$30.7K | 0.19% | 107 |
|
|
2020
Q3 | $770K | Sell |
3,031
-56
| -2% | -$13.9K | 0.24% | 95 |
|
|
2020
Q2 | $728K | Buy |
3,087
+393
| +15% | +$89.7K | 0.24% | 92 |
|
|
2020
Q1 | $546K | Sell |
2,694
-12
| -0.4% | -$2.62K | 0.22% | 99 |
|
|
2019
Q4 | $652K | Buy |
2,706
+210
| +8% | +$46.3K | 0.2% | 107 |
|
|
2019
Q3 | $483K | Buy |
2,496
+283
| +13% | +$54.3K | 0.16% | 127 |
|
|
2019
Q2 | $408K | Sell |
2,213
-10
| -0.4% | -$1.79K | 0.15% | 128 |
|
|
2019
Q1 | $422K | Buy |
2,223
+395
| +22% | +$75.4K | 0.16% | 122 |
|
|
2018
Q4 | $356K | Buy |
1,828
+207
| +13% | +$40.4K | 0.17% | 121 |
|
|
2018
Q3 | $336K | Sell |
1,621
-107
| -6% | -$21.1K | 0.14% | 131 |
|
|
2018
Q2 | $319K | Sell |
1,728
-33
| -2% | -$5.84K | 0.14% | 132 |
|
|
2018
Q1 | $300K | Sell |
1,761
-43
| -2% | -$7.89K | 0.13% | 143 |
|
|
2017
Q4 | $314K | Buy |
1,804
+33
| +2% | +$5.84K | 0.14% | 139 |
|
|
2017
Q3 | $330K | Buy |
1,771
+1,040
| +142% | +$184K | 0.16% | 123 |
|
|
2017
Q2 | $126K | Buy |
731
+341
| +87% | +$55.5K | 0.08% | 172 |
|
|
2017
Q1 | $64K | Sell |
390
-11,025
| -97% | -$1.83M | 0.05% | 188 |
|
|
2016
Q4 | $1.67M | Buy |
11,415
+390
| +4% | +$58.7K | 1.27% | 22 |
|
|
2016
Q3 | $1.84M | Sell |
11,025
-25
| -0.2% | -$4.23K | 1.57% | 15 |
|
|
2016
Q2 | $1.68M | Buy |
11,050
+25
| +0.2% | +$3.89K | 1.51% | 14 |
|
|
2016
Q1 | $1.65M | Hold |
11,025
| – | – | 1.51% | 15 |
|
|
2015
Q4 | $1.79M | Buy |
+11,025
| New | +$1.73M | 1.6% | 14 |
|
Other funds holding AMGN
Grove Bank & Trust's AMGN Position: Q2 2026 in Review
Grove Bank & Trust increased its Amgen (AMGN) stake by 18% in Q2 2026, buying an estimated $172K and bringing the position to 3,253 shares worth $1.18M. The position accounts for 0.12% of the portfolio, ranked #108.
Grove Bank & Trust first reported a position in AMGN in Q4 2015 and has held it in 43 quarters since. The position peaked at $1.84M in Q3 2016. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Grove Bank & Trust held 3,253 shares of Amgen worth $1.18M as of Q2 2026.
- Grove Bank & Trust bought 503 Amgen shares in Q2 2026, an estimated $172K.
- Amgen made up 0.12% of Grove Bank & Trust's portfolio in Q2 2026, its #108 holding.
- Grove Bank & Trust first reported a position in Amgen in Q4 2015 and has held it in 43 quarters since.
- Grove Bank & Trust's Amgen position peaked at $1.84M in Q3 2016.
- 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Grove Bank & Trust's 13F filing for Q2 2026, filed 7 Jul 2026.